Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 81025-04-9
2. D-lactitol Monohydrate
3. Lactitol (monohydrate)
4. Lactitol Hydrate
5. 4-o-beta-d-galactopyranosyl-d-glucitol Monohydrate
6. Uh2k6w1y64
7. (2s,3r,4r,5r)-4-[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,5,6-pentol;hydrate
8. Lactitol Hydrate (jan)
9. Lactitol Hydrate [jan]
10. D-glucitol, 4-o-beta-d-galactopyranosyl-, Hydrate (1:2)
11. Bli-400
12. Smr000499577
13. Nsc-759131
14. Pizensy
15. Unii-uh2k6w1y64
16. Portolac (tn)
17. (2s,3r,4r,5r)-4-(((2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)hexane-1,2,3,5,6-pentaol Hydrate
18. Dsstox_cid_27028
19. Dsstox_rid_82049
20. Dsstox_gsid_47028
21. Mls001076675
22. Mls001361361
23. Mls002207095
24. Schembl230581
25. D-glucitol, 4-o-beta-d-galactopyranosyl-, Monohydrate
26. D-lactitol Monohydrate, ~99%
27. Chembl1200429
28. Dtxsid6047028
29. Lactitol Monohydrate [ii]
30. Lactitol Monohydrate [mi]
31. Hms2231o06
32. Hy-b1389
33. Tox21_302283
34. Mfcd00150767
35. S5282
36. Lactitol Monohydrate [who-dd]
37. Ccg-268187
38. Cs-4859
39. Nsc 759131
40. Ncgc00256064-01
41. As-57306
42. Lactitol Monohydrate [ep Monograph]
43. Cas-81025-04-9
44. D02039
45. D70309
46. A864616
47. Q27291076
48. Lactitol, United States Pharmacopeia (usp) Reference Standard
49. D-glucitol, 4-o-.beta.-d-galactopyranosyl-, Monohydrate
50. Lactitol Monohydrate, European Pharmacopoeia (ep) Reference Standard
51. (2s,3r,4r,5r)-4-((2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)hexane-1,2,3,5,6-pentaol Hydrate
52. (2s,3r,4r,5r)-4-[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,5,6-pentol,hydrate
53. (2s,3r,4r,5r)-4-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexane-1,2,3,5,6-pentol Hydrate
| Molecular Weight | 362.33 g/mol |
|---|---|
| Molecular Formula | C12H26O12 |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 8 |
| Exact Mass | 362.14242626 g/mol |
| Monoisotopic Mass | 362.14242626 g/mol |
| Topological Polar Surface Area | 202 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 343 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
84
PharmaCompass offers a list of Lactitol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lactitol manufacturer or Lactitol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lactitol manufacturer or Lactitol supplier.
PharmaCompass also assists you with knowing the Lactitol API Price utilized in the formulation of products. Lactitol API Price is not always fixed or binding as the Lactitol Price is obtained through a variety of data sources. The Lactitol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A D02039 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of D02039, including repackagers and relabelers. The FDA regulates D02039 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. D02039 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of D02039 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A D02039 supplier is an individual or a company that provides D02039 active pharmaceutical ingredient (API) or D02039 finished formulations upon request. The D02039 suppliers may include D02039 API manufacturers, exporters, distributors and traders.
click here to find a list of D02039 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A D02039 DMF (Drug Master File) is a document detailing the whole manufacturing process of D02039 active pharmaceutical ingredient (API) in detail. Different forms of D02039 DMFs exist exist since differing nations have different regulations, such as D02039 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A D02039 DMF submitted to regulatory agencies in the US is known as a USDMF. D02039 USDMF includes data on D02039's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The D02039 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of D02039 suppliers with USDMF on PharmaCompass.
A D02039 CEP of the European Pharmacopoeia monograph is often referred to as a D02039 Certificate of Suitability (COS). The purpose of a D02039 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of D02039 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of D02039 to their clients by showing that a D02039 CEP has been issued for it. The manufacturer submits a D02039 CEP (COS) as part of the market authorization procedure, and it takes on the role of a D02039 CEP holder for the record. Additionally, the data presented in the D02039 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the D02039 DMF.
A D02039 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. D02039 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of D02039 suppliers with CEP (COS) on PharmaCompass.
D02039 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of D02039 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right D02039 GMP manufacturer or D02039 GMP API supplier for your needs.
A D02039 CoA (Certificate of Analysis) is a formal document that attests to D02039's compliance with D02039 specifications and serves as a tool for batch-level quality control.
D02039 CoA mostly includes findings from lab analyses of a specific batch. For each D02039 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
D02039 may be tested according to a variety of international standards, such as European Pharmacopoeia (D02039 EP), D02039 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (D02039 USP).
